Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Hematologic Neoplasms × pemigatinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Cholangiocarcinoma 9 Acrocephalosyndactylia 6 Carcinoma, Transitional Cell 5 Neoplasm Metastasis 4 Gastrointestinal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Breast Neoplasms 3 Solid Tumor 2 Recurrence 2 Pancreatic Neoplasms 2 Colorectal Neoplasms 2 Carcinoma 2 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Solid Tumor, Miscellaneous 1 Sarcoma 1 Oligodendroglioma 1 Non-Muscle Invasive Bladder Neoplasms 1 Neoplasms 1 Myeloproliferative Disorders 1 Lymphoma, Mantle-Cell 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma, B-Cell 1 Lung Neoplasms 1 Locally Advanced Unresectable Gastric Cancer 1 Leukemia, Myeloid, Acute 1 Hematologic Neoplasms 1 Glioma 1 Glioblastoma 1 Gastrointestinal Stromal Tumors 1

Interventions

Cyclophosphamide 76 fludarabine 65 fludarabine phosphate 40 Tacrolimus 39 Whole-Body Irradiation 37 Mycophenolic Acid 34 Busulfan 30 Melphalan 27 Antilymphocyte Serum 21 thymoglobulin 20 Methotrexate 20 Sirolimus 19 Thiotepa 18 Standard of Care 18 Stem Cell Transplantation 17 Rituximab 17 Azacitidine 17 venetoclax 16 Granulocyte Colony-Stimulating Factor 16 Practice Guidelines as Topic 15 Cytarabine 14 Filgrastim 13 Mesna 12 Bortezomib 12 Nivolumab 10 Peripheral Blood Stem Cell Transplantation 9 Dexamethasone 9 Blood Specimen Collection 9 trametinib 8 Specimen Handling 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05159245 2024-07-15

FINPROVE

Helsinki University Central Hospital

Phase 2 Recruiting

Other hematologic neoplasm

Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡